Guerbet Advances MRI Diagnostics with Innovative Solutions

Guerbet Diagnostic Imaging is focused on improving patient outcomes through innovative solutions tailored for MRI diagnostics. The company’s portfolio includes advanced products and support services designed to enhance every step of the patient journey in diagnostic imaging.

Approved Contrast Agents

Guerbet provides two notable gadolinium-based contrast agents (GBCA) for use in MRI.

• Dotarem® (Gadoteric Acid) is a macrocyclic GBCA approved for use in contrast-enhanced MRI examinations.
• Elucirem™ (Gadopiclenol) is another macrocyclic GBCA available for contrast-enhanced resonance imaging (MRI), produced in both France and the USA.

These agents are integral to the effectiveness of MRI procedures, allowing for enhanced imaging capabilities that support accurate diagnoses.

Guerbet continues to demonstrate its commitment to advancing radiology through innovative solutions that prioritize patient care.